Recent enhancements of minimal residual disease detection by flow-cytometry in chronic lymphocytic leukemia: a study of the French CLL-MRD group

被引：0

作者：

Dahmani, Abdelmalek ^{[1
]}

Arnoulet, Christine ^{[2
]}

Baseggio, Lucile ^{[3
]}

Campos, Lydia ^{[4
]}

Chatelain, Bernard ^{[5
]}

Debliquis, Agathe ^{[6
]}

Drenou, Bernard ^{[6
]}

Jacob, Marie-Christine ^{[7
]}

Legac, Eric ^{[8
]}

Le Garff-Tavernier, Magali ^{[9
]}

Quiney, Claire ^{[9
]}

Robillard, Nelly ^{[10
]}

Solly, Francoise ^{[4
]}

Ticchioni, Michel ^{[11
]}

Cartron, Guillaume ^{[12
]}

Dartigeas, Caroline ^{[13
]}

Feugier, Pierre ^{[14
]}

Leblond, Veronique ^{[15
]}

Lepretre, Stephane ^{[15
]}

Van den Neste, Eric ^{[16
]}

Delfau-Larue, Marie-Helene ^{[17
]}

Cymbalista, Florence ^{[1
]}

Letestu, Remi ^{[1
]}

机构：

[1] Univ Paris 13, Hop Avicenne, AP HP, Bobigny, France

[2] CLCC IPC, Marseille, France

[3] CHU Pierre Benite, Lyon, France

[4] CHU St Priest En Jarez, St Etienne, France

[5] UCL Mont Godinne, Yvoir, France

[6] CH E Muller, Mulhouse, France

[7] EFS, Grenoble, France

[8] CHR Source, Orleans, France

[9] Hop La Pitie Salpetriere, Paris, France

[10] CHU Nantes, Nantes, France

[11] Hop Archet, Nice, France

[12] CHU Montpellier, Montpellier, France

[13] CHU Tours, Tours, France

[14] CHU Nancy, Nancy, France

[15] Ctr Henri Becquerel, F-76038 Rouen, France

[16] UCL St Luc, Brussels, Belgium

[17] CHU Henri Mondor, F-94010 Creteil, France

来源：

LEUKEMIA & LYMPHOMA | 2015年 / 56卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

138

引用

页码：115 / 116

页数：2

共 50 条

[1] Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL): Flow Cytometry (FC) or Immunohistochemistry (IHC)?
Amador-Orliz, C.
Menke, D. M.
Valdez, R.
Jiang, L.
Michael, T. M.
Morice, W. G.
Jevremovic, D.
Shanafelt, T. D.
Hanson, C. A.
LABORATORY INVESTIGATION, 2012, 92 : 322A - 322A
[2] Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL): Flow Cytometry (FC) or Immunohistochemistry (IHC)?
Amador-Ortiz, C.
Menke, D. M.
Valdez, R.
Jiang, L.
Michael, T. M.
Morice, W. G.
Jevremovic, D.
Shanafelt, T. D.
Hanson, C. A.
MODERN PATHOLOGY, 2012, 25 : 322A - 322A
[3] ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) AT FLOW-CYTOMETRY
ORFAO, A
CIUDAD, J
LOPEZBERGES, MC
LOPEZ, A
VIDRIALES, B
CABALLERO, MD
VALVERDE, B
GONZALEZ, M
SANMIGUEL, JF
LEUKEMIA & LYMPHOMA, 1994, 13 : 87 - 90
[4] FLOW CYTOMETRY OR IMMUNOHISTOCHEMISTRY FOR MINIMAL RESIDUAL DISEASE DETECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA?
Hanson, Curtis
Amador-Ortiz, Catalina
Timm, Michael
Morice, William
Jevremovic, Dragan
Shanafelt, Tait
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 : 51 - 52
[5] Detection of minimal residual disease in B chronic lymphocytic leukemia (CLL)
Magnac, C
Sutton, L
Cazin, B
Laurent, C
Binet, JL
Merle-Béral, H
Dighiero, G
Maloum, K
HEMATOLOGY AND CELL THERAPY, 1999, 41 (01) : 13 - 18
[6] DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA BY FLOW-CYTOMETRY
VISSER, JWM
MARTENS, ACM
HAGENBEEK, A
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 468 : 268 - 275
[7] Minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL) via an 8 color flow cytometry panel comprising the signature gene ROR1
Patz, Michaela
Pentok, Barbara
Cremer, Kathrin
Linnartz, Stefanie
Lilienweiss, Esther
Kleinert, Fanni
Hallek, Michael
Kreuzer, Karl-Anton
LEUKEMIA & LYMPHOMA, 2017, 58 : 93 - 94
[8] ROR-1 Is a Highly Discriminative Marker in Flow Cytometric Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL)
Patz, Michaela
Pentok, Barbara
Cremer, Kathrin
Linnartz, Stefanie
Lilienweiss, Esther
Kleinert, Fanni
Hallek, Michael
Kreuzer, Karl-Anton
BLOOD, 2016, 128 (22)
[9] A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study
Rawstron, Andy
Fazi, Claudia
Villamor, Neus
Delgado, Julio
Letestu, Remi
Cymbalista, Florence
Palacio, Carlos
Bosch, Francesc
De Tute, Ruth M.
Liptrot, Stuart
O'Brien, David
Spacek, Martin
Dobber, Johan
Kater, Arnon P.
Gambell, Peter C.
Westerman, David A.
Soosapilla, Asha
Mulligan, Stephen P.
Lozanski, Gerard
Lin, Ke
Pettitt, Andrew R.
Brachtl, Gabi
Egle, Alexander
Williamson, David W.
Sanders, Catherine M.
Robins, Harlan
Boysen, Justin
Shanafelt, Tait D.
Hanson, Curtis A.
Jorgensen, Jeffrey L.
Wierda, William G.
Yuan, Constance
Stetler-Stevenson, Maryalice
Rassenti, Laura
Broome, H. Elizabeth
Kipps, Thomas J.
Hauwel, Mathieu
Marinov, Iuri
Craig, Fiona E.
Josep, Nomdedeu
Moreno, Carol
Stehlikova, Olga
Doubek, Michael
Pospisilova, Sarka
Kreuzer, Karl-Anton
Hallek, Michael
Hillmen, Peter
Montserrat, Emili
Ghia, Paolo
BLOOD, 2014, 124 (21)
[10] Signal transduction in chronic lymphocytic leukemia (CLL) cells by multiparameter flow-cytometry
Palomba, M. L.
Patel, J. P.
Rao, U.
Rastalsky, N.
Lu, S. X.
Houghton, A. N.
Zelenetz, A. D.
van den Brink, M. R.
ANNALS OF ONCOLOGY, 2008, 19 : 192 - 192

← 1 2 3 4 5 →